A new option may be soon be available to smokers who want to quit. A new injectable vaccine is to hit the market from drug maker GlaxoSmithKline.
The vaccine is called NicVAX, and it blocks nicotine from entering the brain, stopping smoking from creating a feeling of pleasure.
Trials have shown a high success rate in stopping smokers from getting back on the wagon if they have managed to quit once.
Products that are available on the market currently do not have consistent success rates.
The relapse rate within a year is fairly high, at nearly 90% according to figures from the American Lung Association.
The vaccine is injected and creates anti-bodies that are bound to the nicotine molecules, which prevent them from entering into the brain.
[Via: Telegraph.co.uk]
